{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:46:14Z","timestamp":1772847974202,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","dmidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.diagmicrobio.2017.06.021","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T23:48:33Z","timestamp":1498866513000},"page":"161-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates"],"prefix":"10.1016","volume":"89","author":[{"given":"Jingyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-2823","authenticated-orcid":false,"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/antibiotics4030267","article-title":"Antimicrobial resistance and reduced susceptibility in Clostridium difficile: potential consequences for induction, treatment, and recurrence of C. difficile infection","volume":"4","author":"Baines","year":"2015","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0010","series-title":"8th ed. Wayne, PA: Document M11-A8","article-title":"Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2012"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0015","series-title":"Twenty-fifth informational supplement, CLSI document M100-S25","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0020","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/JCM.03487-13","article-title":"Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China","volume":"52","author":"Du","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0025","series-title":"Breakpoint tables for interpretation of MICs and zone diameters","article-title":"The European committee on antimicrobial susceptibility testing","author":"EUCAST","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijantimicag.2016.09.009","article-title":"Toxin profiles, PCR ribotypes and resistance patterns of Clostridium difficile: a multicentre study in China, 2012-2013","volume":"48","author":"Gao","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0035","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/JCM.01796-09","article-title":"Multilocus sequence typing of Clostridium difficile","volume":"48","author":"Griffiths","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmii.2014.04.011","article-title":"Clinical impact of Clostridium difficile colonization","volume":"48","author":"Hung","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0060","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1128\/JCM.42.12.5710-5714.2004","article-title":"Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin a), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile","volume":"42","author":"Lemee","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0065","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1128\/JCM.05100-11","article-title":"Divergent rifamycin susceptibilities of Clostridium difficile strains in Canada and Italy and predictive accuracy of rifampin Etest for rifamycin resistance","volume":"49","author":"Miller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/dkl553","article-title":"Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide","volume":"59","author":"Musher","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0075","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"Musher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4292\/wjgpt.v5.i1.1","article-title":"Clinical update for the diagnosis and treatment of Clostridium difficile infection","volume":"5","author":"OldfieldIv","year":"2014","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0085","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1469-0691.2008.02092.x","article-title":"New multiplex PCR method for the detection of Clostridium difficile toxin a (tcdA) and toxin B (tcdB) and the binary toxin (cdtA\/cdtB) genes applied to a Danish strain collection","volume":"14","author":"Persson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2049936115622891","article-title":"Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0095","doi-asserted-by":"crossref","first-page":"37865","DOI":"10.1038\/srep37865","article-title":"The incidence and drug resistance of Clostridium difficile infection in mainland China: a systematic review and meta-analysis","volume":"6","author":"Tang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0100","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1017\/ice.2015.177","article-title":"Impact of toxigenic Clostridium difficile colonization on the risk of Subsequent C. difficile infection in intensive care unit patients","volume":"36","author":"Tschudin-Sutter","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijantimicag.2012.01.005","article-title":"Potential protective role of linezolid against Clostridium difficile infection","volume":"39","author":"Valerio","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2017.06.021_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12879-016-1729-2","article-title":"Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317302122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889317302122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T14:29:26Z","timestamp":1535639366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889317302122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0732889317302122"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.06.021","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of Clostridium difficile isolates from ICU colonized patients revealed alert to ST-37 (RT 017) isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}